Tsoi, H.; Tsang, W.-C.; Man, E.P.S.; Leung, M.-H.; You, C.-P.; Chan, S.-Y.; Chan, W.-L.; Khoo, U.-S.
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer. Int. J. Mol. Sci. 2022, 23, 12290.
https://doi.org/10.3390/ijms232012290
AMA Style
Tsoi H, Tsang W-C, Man EPS, Leung M-H, You C-P, Chan S-Y, Chan W-L, Khoo U-S.
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer. International Journal of Molecular Sciences. 2022; 23(20):12290.
https://doi.org/10.3390/ijms232012290
Chicago/Turabian Style
Tsoi, Ho, Wai-Chung Tsang, Ellen P. S. Man, Man-Hong Leung, Chan-Ping You, Sum-Yin Chan, Wing-Lok Chan, and Ui-Soon Khoo.
2022. "Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer" International Journal of Molecular Sciences 23, no. 20: 12290.
https://doi.org/10.3390/ijms232012290
APA Style
Tsoi, H., Tsang, W.-C., Man, E. P. S., Leung, M.-H., You, C.-P., Chan, S.-Y., Chan, W.-L., & Khoo, U.-S.
(2022). Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer. International Journal of Molecular Sciences, 23(20), 12290.
https://doi.org/10.3390/ijms232012290